Loading company details...
Beta
Latest Form 4 (Sep 28, 2026): Louis Edward Tamayo (Chief Financial Officer): Grant/Award of 54,750 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Louis Edward Tamayo, Chief Financial Officer | Grant/Award | 54,750 | n/a |
| Sep 28, 2026 | Narinder Pal Bhalla, Chief Medical Officer | Grant/Award | 2,714 | $9.7K |
| Sep 28, 2026 | Jose Manuel Otero, Chief Operating Officer | Grant/Award | 2,110 | $5.6K |
| Sep 28, 2026 | Richard Nolan Townsend, Chief Executive Officer | Grant/Award | 2,306 | $6.1K |
| Aug 19, 2026 | Louis Edward Tamayo, Chief Financial Officer | Sale | 4,117 | $20.2K |
| Aug 19, 2026 | Richard Nolan Townsend, Chief Executive Officer | Sale | 3,345 | $16.6K |
| Aug 19, 2026 | Jose Manuel Otero, Chief Operating Officer | Sale | 1,304 | $6.5K |
| Jul 1, 2026 | Louis Edward Tamayo, Chief Financial Officer | Grant/Award | 12,000 | n/a |
| Jul 1, 2026 | Jose Manuel Otero, Chief Operating Officer | Grant/Award | 12,060 | n/a |
| Jul 1, 2026 | Narinder Pal Bhalla, Chief Medical Officer | Grant/Award | 55,000 | n/a |